- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Purpose Bitcoin ETF
Soma Gold Corp.
Silver47 Exploration
Black Swan Graphene
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Life Spine Announces Initial Cases and Multiple Surgeries for PROLIFT® Expandable Interbody System
HUNTLEY, Ill.–(BUSINESS WIRE)–Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the company has successfully completed initial cases with the PROLIFT Expandable Interbody System, which restores disc height, in-situ, for minimally invasive PLIF, TLIF and oblique approaches. The U.S. Food and …
HUNTLEY, Ill.–(BUSINESS WIRE)–Life Spine, a medical device company that designs, develops,
manufactures and markets products for the surgical treatment of spinal
disorders, announced today that the company has successfully completed
initial cases with the PROLIFT Expandable Interbody System, which
restores disc height, in-situ, for minimally invasive PLIF, TLIF and
oblique approaches. The U.S. Food and Drug Administration (FDA) provided
510(k) marketing clearance to the PROLIFT System in March 2016.
“The biggest challenge in performing interbody fusions is to place a
large enough spacer without excessive traction along the nerves. The
ProLift device allows for standard protection of the neurological
structures and little to no actual traction applied to the nerves,” said
Alexander Bailey, MD, of Precision Spine & Orthopaedic Specialists in
Kansas City, Kansas. “As an added benefit of this design, the in-situ
distraction achieved after placement in the desired location creates a
situation in which migration or expulsion is nearly eliminated. I found
the design intuitive and easy to use. Additionally, it saves procedural
time by not requiring segmental compression, is safer due to small
initial insertion size, and meets my needs for this type of challenging
surgery.”
“During my initial procedures, bilateral grafts were delivered through
two-inch incision sites which allowed for minimal muscle disruption;
allowing my patients to go home post-op day one. Distraction
capabilities were easily maximized, and used in conjunction with
CENTERLINE™ Midline Screws, I was able to create a minimally
invasive yet robust final construct,” said John Anson, MD, FACS, of the
Spine and Brain Institute of Las Vegas, Nevada.
PROLIFT is scheduled for limited release in the second quarter of 2016,
with full product release expected later in the year.
About Life Spine
Life Spine is dedicated to improving the quality of life for spinal
patients by increasing procedural efficiency and efficacy through
innovative design, uncompromising quality standards, and the most
technologically advanced manufacturing platforms. Life Spine, which is
privately held, is based in Huntley, Illinois. For more information,
please visit: https://www.lifespine.com.
Life Spine is a registered trademark.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.